Updated on 31 July 2014
Solvadi can cure Hepatitis C, without any side effects
Singapore: A new breakthrough drug for hepatitis C that cures without any side effects, in a short regimen of 12 weeks was thought to be a boon to the 80,000 people worldwide who fall prey to the liver disease.
However, patients need to pay a steep price of $1,000 for each pill. That would be a whopping $84,000 for a typical 12-week course of treatment.
The drug under controversy is sofosbuvir, called Solvadi by its manufacturer, Gilead Sciences. Its effectiveness in treating hepatitis C is so pronounced that the US regulators designated it as a "breakthrough therapy" when they approved it for US markets last year.
The high prices brought howls of protests from activists accusing Gilead for charging hefty prices for their wonder drug and making it ‘out of reach' for the common man.
Mr Karyn Kaplan, director, international Hepatitis and HIV policy and advocacy for New York, questioned Gilead on their pricing model stating that a life-saving drug must be made available at affordable costs.